FI970331A - Lääkkeen antokoostumus virustenvastaisten aineiden nenään toteutettavaa antoa varten - Google Patents

Lääkkeen antokoostumus virustenvastaisten aineiden nenään toteutettavaa antoa varten Download PDF

Info

Publication number
FI970331A
FI970331A FI970331A FI970331A FI970331A FI 970331 A FI970331 A FI 970331A FI 970331 A FI970331 A FI 970331A FI 970331 A FI970331 A FI 970331A FI 970331 A FI970331 A FI 970331A
Authority
FI
Finland
Prior art keywords
antiviral agents
nasal administration
drug composition
drug
nasal
Prior art date
Application number
FI970331A
Other languages
English (en)
Swedish (sv)
Other versions
FI970331A0 (fi
Inventor
Peter Watts
Lisbeth Illum
Original Assignee
Danbiosyst Uk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Danbiosyst Uk filed Critical Danbiosyst Uk
Publication of FI970331A0 publication Critical patent/FI970331A0/fi
Publication of FI970331A publication Critical patent/FI970331A/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1658—Proteins, e.g. albumin, gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A61K38/1774—Immunoglobulin superfamily (e.g. CD2, CD4, CD8, ICAM molecules, B7 molecules, Fc-receptors, MHC-molecules)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Otolaryngology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
FI970331A 1994-07-26 1997-01-27 Lääkkeen antokoostumus virustenvastaisten aineiden nenään toteutettavaa antoa varten FI970331A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9414966A GB9414966D0 (en) 1994-07-26 1994-07-26 Pharmaceutical compositions for the nasal administration of antiviral agents
PCT/GB1995/001735 WO1996003142A1 (en) 1994-07-26 1995-07-24 Drug delivery composition for the nasal administration of antiviral agents

Publications (2)

Publication Number Publication Date
FI970331A0 FI970331A0 (fi) 1997-01-27
FI970331A true FI970331A (fi) 1997-01-27

Family

ID=10758832

Family Applications (1)

Application Number Title Priority Date Filing Date
FI970331A FI970331A (fi) 1994-07-26 1997-01-27 Lääkkeen antokoostumus virustenvastaisten aineiden nenään toteutettavaa antoa varten

Country Status (7)

Country Link
EP (1) EP0773791A1 (fi)
JP (1) JPH10506376A (fi)
CA (1) CA2195639A1 (fi)
FI (1) FI970331A (fi)
GB (2) GB9414966D0 (fi)
NO (1) NO970252L (fi)
WO (1) WO1996003142A1 (fi)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5879712A (en) 1995-06-07 1999-03-09 Sri International Method for producing drug-loaded microparticles and an ICAM-1 dosage form so produced
DE69722594T2 (de) * 1996-03-06 2004-04-29 Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield Pulverförmiges arzneimittel enthaltend interzelluläres adhäsionsmolekül
GB9700624D0 (en) 1997-01-14 1997-03-05 Danbiosyst Uk Drug delivery composition
GB9707934D0 (en) * 1997-04-18 1997-06-04 Danbiosyst Uk Improved delivery of drugs to mucosal surfaces
US6391452B1 (en) 1997-07-18 2002-05-21 Bayer Corporation Compositions for nasal drug delivery, methods of making same, and methods of removing residual solvent from pharmaceutical preparations
IL133882A0 (en) * 1997-07-18 2001-04-30 Bayer Ag Process for making an intranasal drug delivery system
JP2004500305A (ja) * 1997-10-31 2004-01-08 フアルマシア・コーポレーシヨン ゲランゴムゲルを含む徐放性組成物
JP4754067B2 (ja) * 1997-12-02 2011-08-24 アルキメデス ディヴェロプメント リミテッド 鼻孔投与用組成物
GB0015682D0 (en) * 2000-06-28 2000-08-16 Bristol Myers Squibb Co Sprayable wound care composition
GB2378383A (en) * 2001-06-06 2003-02-12 Gursharan Moonga Nasal delivery of pharmaceutical compositions in powder form
GB0300531D0 (en) 2003-01-10 2003-02-12 West Pharm Serv Drug Res Ltd Pharmaceutical compositions
GB0328186D0 (en) 2003-12-05 2004-01-07 West Pharm Serv Drug Res Ltd Intranasal compositions
GB0403938D0 (en) * 2004-02-21 2004-03-24 West Pharm Serv Drug Res Ltd Chitosan containing solution
US20100028447A1 (en) 2007-01-22 2010-02-04 Targacept, Inc. Intranasal, Buccal, And Sublingual Administration Of Metanicotine Analogs
DE102008007759B4 (de) 2007-12-04 2009-09-24 Atlantichem Gmbh Mittel zum Verhindern von Verfärbungen beim Waschen von Textilien

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4946870A (en) * 1986-06-06 1990-08-07 Union Carbide Chemicals And Plastics Company Inc. Delivery systems for pharmaceutical or therapeutic actives
EP0314863B1 (en) * 1987-11-02 1994-12-07 Baylor College Of Medicine Use of ICAM-1 or its functional derivatives for the treatment of non-specific inflammation
ES2141076T3 (es) * 1988-09-01 2000-03-16 Bayer Ag Proteina del receptor de rinovirus humano que inhibe la infectividad del virus.
SE8804164A0 (sv) * 1988-11-17 1990-05-18 Per Prisell Farmaceutisk beredning
GB2237510B (en) * 1989-11-04 1993-09-15 Danbiosyst Uk Small particle drug compositions for nasal administration
AU2763692A (en) * 1991-10-02 1993-05-03 Boehringer Ingelheim Pharmaceuticals, Inc. Use of intercellular adhesion molecules, and their binding ligands in the treatment of asthma
RU94046450A (ru) * 1992-06-22 1996-10-10 Майлз Инк. (US) Мультимерная icam-i, способ усиления связывания icam-i с лигандом, фармацевтическая композиция, способ индукции декансидации, способ необратимого ингибирования заражения клеток
GB9310412D0 (en) * 1993-05-20 1993-07-07 Danbiosyst Uk Nasal nicotine system

Also Published As

Publication number Publication date
WO1996003142A1 (en) 1996-02-08
AU2988695A (en) 1996-02-22
EP0773791A1 (en) 1997-05-21
GB9700817D0 (en) 1997-03-05
CA2195639A1 (en) 1996-02-08
NO970252D0 (no) 1997-01-21
GB2305606A (en) 1997-04-16
FI970331A0 (fi) 1997-01-27
NO970252L (no) 1997-01-21
AU707462B2 (en) 1999-07-08
JPH10506376A (ja) 1998-06-23
GB9414966D0 (en) 1994-09-14
GB2305606B (en) 1998-08-05

Similar Documents

Publication Publication Date Title
NO20002851D0 (no) Blandinger for nasal administrasjon av medikamenter
MX9101175A (es) Composicion farmaceutica para administracion nasal
NO20003161D0 (no) Blandinger for nasal administrasjon av kannabinoider
FI954228A (fi) Infuusiolaite hoitoaineen jaksottaista tai jatkuvaa antamista varten
KR950700754A (ko) 신규의 약물(novel medicament)
IT1284049B1 (it) Medicamento per somministrazione nasale
HRP960300B1 (en) Inhaler for administration of blister-packed medicaments
IT9021457A0 (it) Dispositivo per l'inalazione boccale di farmaci aerosol
FI970331A (fi) Lääkkeen antokoostumus virustenvastaisten aineiden nenään toteutettavaa antoa varten
FI930656A (fi) Komposition foer nasal behandling
BR9610983A (pt) Formas estáveis de administração farmacêuticas contendo paratormônio
EE9500059A (et) Asendatud 4-fenüül-6-aminonikotiinhappe derivaatide kasutamine ravimitena
IT1214683B (it) Composizioni farmaceutiche nasali
NO950134D0 (no) Formuleringer for oralt administrerte farmasöytiske midler
IT9019112A1 (it) Composizioni farmaceutiche e forme di dosaggio per la somministrazione orale di calcitonina
IT1223132B (it) Composizione farmaceutica per somministrazione nasale
ITBS920130A1 (it) Composizione farmaceutiche topiche per le allergie respiratorie
KR950032276U (ko) 의약품 투여용 피부 흠집 형성구
FR2725133B1 (fr) Composition pharmaceutique de fantofarone pour administration orale
NO920647L (no) Nasalt farmasoeytisk preparat
IT1295003B1 (it) Composizioni farmaceutiche per il trattamento dell'herpes simplex
ITMI940562A0 (it) Composizioni farmaceutiche di calcitonina somministrabili per via rettale
ITMI913306A0 (it) Composizioni farmaceutiche per la somministrazione nasale di polipeptidi
BR9304388A (pt) Composição terapêutica de uso nasal
ITMI921253A0 (it) Composizione farmaceutica avente attivita' antivirale

Legal Events

Date Code Title Description
MA Patent expired